Search research articles
Contact Us
Filters
Showing results (91-100 of 121) with videos related to
Page
of 13
Sort By:
Journal of Thoracic Disease
|
June 16, 2023
Analysis of real-world data to investigate evolving treatment sequencing patterns in advanced non-small cell lung cancers and their impact on survival
Zongzhi Liu, Kyeryoung Lee, David Cohn, et al.
Annals of Translational Medicine
|
April 3, 2023
The prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer
Zhipeng Wang, Haoyang Liu, Jinge Zhao, et al.
The Oncologist
|
September 6, 2022
Plasma Exosomal AKR1C3 mRNA Expression Is a Predictive and Prognostic Biomarker in Patients with Metastatic Castration-Resistant Prostate Cancer
Sha Zhu, Yuchao Ni, Zilin Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 14, 2024
Integration Analysis of Single-Cell Multi-Omics Reveals Prostate Cancer Heterogeneity
Xiaojie Bian, Wenfeng Wang, Mierxiati Abudurexiti, et al.
Oncotarget
|
September 15, 2017
The prognostic implication of intraductal carcinoma of the prostate in metastatic castration-resistant prostate cancer and its potential predictive value in those treated with docetaxel or abiraterone as first-line therapy
Jinge Zhao, Pengfei Shen, Guangxi Sun, et al.
Asian Journal of Surgery
|
November 14, 2022
The therapeutic efficacy of radical prostatectomy and external beam radiation therapy in patients with different pathological patterns of prostate cancer
Jinge Zhao, Guangxi Sun, Fengnian Zhao, et al.
European Journal of Medical Research
|
July 20, 2024
Epigenetic modification of PHLDA2 is associated with tumor microenvironment and unfavorable outcome of immune checkpoint inhibitor-based therapies in clear cell renal cell carcinoma
Junjie Zhao, Xiuyi Pan, Zilin Wang, et al.
Cell Death & Disease
|
April 15, 2021
Directly targeting c-Myc contributes to the anti-multiple myeloma effect of anlotinib
Yang Cao, Huizhuang Shan, Meng Liu, et al.
The Prostate
|
August 22, 2019
Does ductal adenocarcinoma of the prostate (DA) have any prognostic impact on patients with de novo metastatic prostate cancer?
Tao Wu, Jinge Zhao, Zhenhua Liu, et al.
The Prostate
|
April 29, 2015
The presence and clinical implication of intraductal carcinoma of prostate in metastatic castration resistant prostate cancer
Zhibin Chen, Ni Chen, Pengfei Shen, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 121) with videos related to
Sort By:
Page
of 13
Journal of Thoracic Disease
|
June 16, 2023
Analysis of real-world data to investigate evolving treatment sequencing patterns in advanced non-small cell lung cancers and their impact on survival
Zongzhi Liu, Kyeryoung Lee, David Cohn, et al.
Annals of Translational Medicine
|
April 3, 2023
The prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer
Zhipeng Wang, Haoyang Liu, Jinge Zhao, et al.
The Oncologist
|
September 6, 2022
Plasma Exosomal AKR1C3 mRNA Expression Is a Predictive and Prognostic Biomarker in Patients with Metastatic Castration-Resistant Prostate Cancer
Sha Zhu, Yuchao Ni, Zilin Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 14, 2024
Integration Analysis of Single-Cell Multi-Omics Reveals Prostate Cancer Heterogeneity
Xiaojie Bian, Wenfeng Wang, Mierxiati Abudurexiti, et al.
Oncotarget
|
September 15, 2017
The prognostic implication of intraductal carcinoma of the prostate in metastatic castration-resistant prostate cancer and its potential predictive value in those treated with docetaxel or abiraterone as first-line therapy
Jinge Zhao, Pengfei Shen, Guangxi Sun, et al.
Asian Journal of Surgery
|
November 14, 2022
The therapeutic efficacy of radical prostatectomy and external beam radiation therapy in patients with different pathological patterns of prostate cancer
Jinge Zhao, Guangxi Sun, Fengnian Zhao, et al.
European Journal of Medical Research
|
July 20, 2024
Epigenetic modification of PHLDA2 is associated with tumor microenvironment and unfavorable outcome of immune checkpoint inhibitor-based therapies in clear cell renal cell carcinoma
Junjie Zhao, Xiuyi Pan, Zilin Wang, et al.
Cell Death & Disease
|
April 15, 2021
Directly targeting c-Myc contributes to the anti-multiple myeloma effect of anlotinib
Yang Cao, Huizhuang Shan, Meng Liu, et al.
The Prostate
|
August 22, 2019
Does ductal adenocarcinoma of the prostate (DA) have any prognostic impact on patients with de novo metastatic prostate cancer?
Tao Wu, Jinge Zhao, Zhenhua Liu, et al.
The Prostate
|
April 29, 2015
The presence and clinical implication of intraductal carcinoma of prostate in metastatic castration resistant prostate cancer
Zhibin Chen, Ni Chen, Pengfei Shen, et al.
Page
of 13